WCCT expands clinical research services

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/amenic181)
(Image: iStock/amenic181)

Related tags: Medicine, Clinical trial

The global contract research organization (CRO) has announced an expanded clinical research service offering after merging with Medelis last year.

We believe there is a need in the marketplace for a midsized CRO with the specialization and research capabilities of a big CRO, but without the cost structure and typical headaches that can accompany working with a big CRO​,” David Fox, Executive Vice President, Client Services, told Outsourcing-Pharma.com.

Being a specialty CRO with phase I sites enables us to provide services to our sponsors from very early in the clinical development process right up until drug and/or device approval​,” explained Fox, adding that as a midsize CRO it is also able to place a “greater focus on PM and CRA retention​.”

The company’s expanded services include clinical research sites and full-service study management for early-stage clinical research and specialized therapies and medicines development.

Together, WCCT and Medelis are continuing our vision of becoming the global leader in the development of specialized medicines and therapies​,” said Fox.

Related news

Related products

show more

QPS: Global Custom-Built Research Services

QPS: Global Custom-Built Research Services

QPS | 16-Dec-2019 | Product Brochure

Performing complex studies in special populations with remarkable agility. Clinical research just got better with QPS’ Custom-Built Research Services....

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Related suppliers

Follow us

Products

View more

Webinars